US 8334282
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted A61PA61P1/16A61P3/04
Quick answer
US patent 8334282 (Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes) held by Jenrin Discovery, LLC expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/16, A61P3/04, A61P3/06, A61P3/10